{"log_id": 282315853695657570, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 1e-06, "average": 0.999325, "min": 0.997327}, "location": {"width": 125, "top": 138, "height": 25, "left": 187}, "words": "进行急诊治疗"}, {"probability": {"variance": 2e-06, "average": 0.999202, "min": 0.997006}, "location": {"width": 86, "top": 182, "height": 25, "left": 186}, "words": "皮肤反应"}, {"probability": {"variance": 0.001549, "average": 0.981997, "min": 0.820858}, "location": {"width": 810, "top": 224, "height": 32, "left": 224}, "words": " NSAIDS,包括本品可能引起致命的、严重的皮肤不良反应,例如剥脱性皮炎、SJS和TEN"}, {"probability": {"variance": 0.007816, "average": 0.979234, "min": 0.427623}, "location": {"width": 859, "top": 264, "height": 37, "left": 184}, "words": "这些严重事件可在没有征兆的情况下出现。应告知患严重皮肤反应的症状和体征在第一次出"}, {"probability": {"variance": 2e-05, "average": 0.995996, "min": 0.981741}, "location": {"width": 452, "top": 309, "height": 26, "left": 184}, "words": "现皮肤皮疹或过敏反应的其他征象时,应停用本品"}, {"probability": {"variance": 0, "average": 0.999671, "min": 0.999263}, "location": {"width": 87, "top": 350, "height": 27, "left": 183}, "words": "注意事项"}, {"probability": {"variance": 0.002691, "average": 0.974558, "min": 0.814751}, "location": {"width": 565, "top": 391, "height": 34, "left": 225}, "words": "避免与其它非甾体抗炎药,包括选择性COX2抑制剂合并用药"}, {"probability": {"variance": 0.00783, "average": 0.971219, "min": 0.590215}, "location": {"width": 777, "top": 433, "height": 36, "left": 225}, "words": "根据控制症状的需要,在最短治疗时间内使用最低有效剂量,可以使不良反应降到最低"}, {"probability": {"variance": 0.000269, "average": 0.989879, "min": 0.942359}, "location": {"width": 647, "top": 476, "height": 33, "left": 224}, "words": "本品的致癌性试验尚未完成,累积用药时间暂限定在24周内(含2周)"}, {"probability": {"variance": 0.003567, "average": 0.972578, "min": 0.694443}, "location": {"width": 858, "top": 516, "height": 39, "left": 181}, "words": "通常:本品不能用于替代皮质类固醇激素或治疗皮质类固醇激素缺乏。骤然停用皮质类固醇激素"}, {"probability": {"variance": 0.002977, "average": 0.982343, "min": 0.725139}, "location": {"width": 840, "top": 559, "height": 37, "left": 180}, "words": "会导致需皮质类固醇激素控制的疾病的恶化。长期使用皮质类固醇激素治疗的患者如决定停药"}, {"probability": {"variance": 0.008401, "average": 0.956683, "min": 0.75179}, "location": {"width": 125, "top": 604, "height": 24, "left": 181}, "words": "则应逐渐减量"}, {"probability": {"variance": 0.004271, "average": 0.981191, "min": 0.587938}, "location": {"width": 816, "top": 643, "height": 35, "left": 220}, "words": "假定非感染性疼痛与感染会并存在时,本晶减轻炎症和缓解发热的药理学特性会减弱这些阳"}, {"probability": {"variance": 5e-06, "average": 0.998254, "min": 0.992277}, "location": {"width": 248, "top": 686, "height": 27, "left": 180}, "words": "性体征在诊断感染上的价值"}, {"probability": {"variance": 0.039701, "average": 0.828062, "min": 0.547275}, "location": {"width": 113, "top": 681, "height": 58, "left": 904}, "words": "药股分"}, {"probability": {"variance": 0.013805, "average": 0.942626, "min": 0.680433}, "location": {"width": 129, "top": 728, "height": 25, "left": 178}, "words": "对肝脏的影响"}, {"probability": {"variance": 0.008236, "average": 0.971028, "min": 0.477496}, "location": {"width": 750, "top": 769, "height": 34, "left": 219}, "words": "本晶尚未在肝功能不全的患者中进行相关研究:故不建议肝功能不全的患者使用"}, {"probability": {"variance": 0.008275, "average": 0.969704, "min": 0.50086}, "location": {"width": 818, "top": 809, "height": 37, "left": 218}, "words": "在关于 NSAIDS的临床研究中,多至15%服用的患者会有一项或多项肝脏实验室指标的临界"}, {"probability": {"variance": 0.005376, "average": 0.965479, "min": 0.675553}, "location": {"width": 858, "top": 851, "height": 37, "left": 176}, "words": "增高,约有1%的患者会出现显著的ALT或AST的升高(高于正常值上限的三倍或更多倍)。继续"}, {"probability": {"variance": 0.006735, "average": 0.973196, "min": 0.635604}, "location": {"width": 856, "top": 892, "height": 38, "left": 177}, "words": "治疗,这些实验室异常值可能进展、保持稳定或恢复正常。在 NSAIDS,包括塞来青布胶囊的治"}, {"probability": {"variance": 0.001809, "average": 0.980099, "min": 0.846469}, "location": {"width": 858, "top": 934, "height": 37, "left": 176}, "words": "疗中,有罕见的严重肝脏反应的报道,包括黄疸型和致命的暴发型肝炎,肝坏死和肝功能衰竭(有"}, {"probability": {"variance": 0.001661, "average": 0.974254, "min": 0.848023}, "location": {"width": 858, "top": 976, "height": 37, "left": 175}, "words": "些会致命)。若服用本品的患者有提示肝脏功能不全的症状和或体征有肝脏功能不全的实验"}, {"probability": {"variance": 0.01204, "average": 0.954787, "min": 0.514991}, "location": {"width": 858, "top": 1021, "height": 34, "left": 176}, "words": "室证据:应仔细监测肝脏功能恶化发展的证据。若症状和体征均提示肝脏疾病进展,或有全身表"}, {"probability": {"variance": 0.015954, "average": 0.935899, "min": 0.509736}, "location": {"width": 427, "top": 1064, "height": 28, "left": 172}, "words": "现如:嗜酸细胞增多症,皮疹等):应停用本品"}, {"probability": {"variance": 1e-06, "average": 0.999329, "min": 0.997685}, "location": {"width": 170, "top": 1106, "height": 26, "left": 172}, "words": "对血液系统的影响"}, {"probability": {"variance": 0.010904, "average": 0.961224, "min": 0.506692}, "location": {"width": 818, "top": 1147, "height": 33, "left": 212}, "words": "本品临床研究中患者未出现贫血,据文献报道使用塞来背布胶囊治疗的患者中有时会出现贫"}, {"probability": {"variance": 0.005945, "average": 0.976376, "min": 0.528554}, "location": {"width": 858, "top": 1188, "height": 33, "left": 171}, "words": "血。长期应用本品的患者如果出现任何贫血或失血的症状和体征,应该检查血红蛋白和血细胞比"}, {"probability": {"variance": 0, "average": 0.999969, "min": 0.999969}, "location": {"width": 27, "top": 1232, "height": 25, "left": 169}, "words": "容"}, {"probability": {"variance": 0, "average": 0.999538, "min": 0.999292}, "location": {"width": 86, "top": 1274, "height": 25, "left": 170}, "words": "伴有哮"}, {"probability": {"variance": 0.007507, "average": 0.966899, "min": 0.615309}, "location": {"width": 817, "top": 1314, "height": 34, "left": 212}, "words": "哮喘患者可能因阿司匹林过敏面诱发哮喘。有阿司匹林诱发哮喘的患者使用阿司匹林会导致"}, {"probability": {"variance": 0.013747, "average": 0.959461, "min": 0.370297}, "location": {"width": 860, "top": 1355, "height": 34, "left": 168}, "words": "严重的可能致命的支气管痉挛。由于这些阿司林过敏的患中阿司匹林和其它非体类抗炎药"}, {"probability": {"variance": 0.012177, "average": 0.96148, "min": 0.376103}, "location": {"width": 857, "top": 1396, "height": 36, "left": 170}, "words": "物之间的交叉反应(包括支气管痉挛)已有报道,故本品不应用于此类型的阿司林过敏患者,在"}, {"probability": {"variance": 0.018271, "average": 0.948161, "min": 0.439011}, "location": {"width": 333, "top": 1440, "height": 27, "left": 168}, "words": "伴有哮喘的患者中应用本也要谨慎"}, {"probability": {"variance": 0.002758, "average": 0.965142, "min": 0.874367}, "location": {"width": 83, "top": 1482, "height": 25, "left": 168}, "words": "患者须知"}, {"probability": {"variance": 0.001456, "average": 0.985808, "min": 0.805244}, "location": {"width": 513, "top": 1524, "height": 29, "left": 198}, "words": "在开始本品治疗前和治疗过程中应定期告知患者以下信息"}], "language": 3}